Catherine Arnaud

Epidemiology of Autism Spectrum Disorders in French Children Aged 8

Malika Delobel‐Ayoub, Aouicha Abid, Dana Klapouszczak, Éloïse Berger et autres

PURPOSE: Reliable and up-to-date data on autism spectrum disorder (ASD) prevalence in France remain limited. This study aimed to describe long-term trends in ASD diagnosis rates at age 8 in a French county between 2003 and 2024 and to provide a detailed …

fr (code pays fourni par la source)

Accompagner l’allaitement à la crèche : recueil, conservation et distribution du lait maternel

Catherine Arnaud

Risque de troubles envahissants du développement chez les enfants exposés in utero aux benzodiazépines

Laurane Delteil, Mélanie Araujo, Catherine Arnaud, Isabelle M. E. Lacroix et autres

fr (code pays fourni par la source)

Oxytocin in infants with Prader-Willi syndrome to improve dysphagia and disease trajectory

M. Tauber, Gwénaëlle Diene, Pascale Fichaux-Bourin, Graziella Pinto et autres

OBJECTIVE: Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder with a characteristic trajectory. Infants display hypotonia, poor social and feeding skills, and high risk of choking, which have been shown to improve after oxytocin (OT) treatment. Our aim is to demonstrate the …

fr, be, de (code pays fourni par la source)

Additional file 1 of Oxytocin in infants with Prader-Willi syndrome to improve dysphagia and disease trajectory

M. Tauber, Gwénaëlle Diene, Pascale Fichaux-Bourin, Graziella Pinto et autres

Supplementary Material 1

fr, be, de (code pays fourni par la source)

Additional file 1 of Oxytocin in infants with Prader-Willi syndrome to improve dysphagia and disease trajectory

M. Tauber, Gwénaëlle Diene, Pascale Fichaux-Bourin, Graziella Pinto et autres

Supplementary Material 1

fr, be, de (code pays fourni par la source)

Oxytocin in infants with Prader-Willi syndrome to improve dysphagia and disease trajectory

M. Tauber, Gwénaëlle Diene, Pascale Fichaux-Bourin, Graziella Pinto et autres

Abstract Objective Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder with a characteristic trajectory. Infants display hypotonia, poor social and feeding skills, and high risk of choking, which have been shown to improve after oxytocin (OT) treatment. Our aim is to demonstrate …

fr, be, de (code pays fourni par la source)

Oxytocin in infants with Prader-Willi syndrome to improve dysphagia and disease trajectory

M. Tauber, Gwénaëlle Diene, Pascale Fichaux-Bourin, Graziella Pinto et autres

Abstract Objective Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder with a characteristic trajectory. Infants display hypotonia, poor social and feeding skills, and high risk of choking, which have been shown to improve after oxytocin (OT) treatment. Our aim is to demonstrate …

fr, be, de (code pays fourni par la source)

Attention, gros mots !

Catherine Arnaud

A European study of non-progressive ataxia in children

Kate Himmelmann, Catherine Arnaud

The distinction between the definition and description of cerebral palsy

Ingeborg Krägeloh‐Mann, Malika Delobel‐Ayoub, Antigone Papavasiliou, Oliver Perra et autres

This letter to the editor is on the Proposed updated description of cerebral palsy by Dan et al. To view this paper visit https://doi.org/10.1111/dmcn.16274 .

de, es, fr, gr, gb, dk, pt (code pays fourni par la source)

A new tool to study the effects of in utero medication exposure on neurodevelopment in children

Laurane Delteil, Caroline Hurault‐Delarue, Catherine Arnaud, Dana Klapouszczak et autres

Here we describe the implementation of a new tool that would allow to assess the risk of serious disability following in utero exposure to medications. The overall objective was to enrich the EFEMERIS database [Évaluation chez la Femme Enceinte des MEdicaments et …

fr (code pays fourni par la source)